David Herbert Robbins MD MSc, FASGE, AGAF, FACG
Advanced Endoscopic Interventional
Program Director www.davidrobbinsmd.com
Join to View Full Profile
100 E 77th StSecond floorNew York, NY 10075
Phone+1 212-434-3427
Fax+1 212-434-6275
Dr. Robbins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2001 - 2005
University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2001- Icahn School of Medicine at Mount SinaiClass of 1999
Certifications & Licensure
NY State Medical License 2001 - 2026
SC State Medical License 2003 - 2004
PA State Medical License 2000 - 2001
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2014
Publications & Presentations
PubMed
- 18 citationsEUS-guided gastroenterostomy versus surgical gastroenterostomy for the management of gastric outlet obstruction: a systematic review and meta-analysis.Anand Kumar, Saurabh Chandan, Babu P Mohan, Pradeep R Atla, Evin J McCabe
Endoscopy International Open. 2022-04-01 - 26 citationsDonning a New Approach to the Practice of Gastroenterology: Perspectives From the COVID-19 Pandemic Epicenter.Amrita Sethi, Arun Swaminath, Melissa Latorre, Daniel S. Behin, Daniela Jodorkovsky
Clinical Gastroenterology and Hepatology. 2020-07-01 - 17 citationsPreparation in the Big Apple: New York City, a New Epicenter of the COVID-19 Pandemic.Seth A. Gross, David H. Robbins, David A. Greenwald, Felice Schnoll-Sussman, Mark Pochapin
The American Journal of Gastroenterology. 2020-06-01
Press Mentions
Two More Heartburn Meds Recalled Due to Possible CarcinogenJanuary 10th, 2020
CVS and Walgreens Stop Selling Zantac After Cancer-Causing Chemical DetectedOctober 1st, 2019
Medicolegal Issues Hinder Adoption of Resect–Discard for PolypsMarch 25th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
